BMS Sees Growth Products’ Contributions To Total Revenue Increase In Q3
Camzyos, Breyanzi Sales Rose By Triple Digits
With its two biggest sellers losing exclusivity in 2028, the pressure is on for Bristol Myers Squibb to grow revenue through new products, which made meaningful contributions in Q3.
